Colorectal cancer intrinsic subtypes predict chemotherapy benefit, deficient mismatch repair and epithelial‐to‐mesenchymal transitionPaul Roepman, Iris Simón, Sun Tian et al.|International Journal of Cancer|2013Cited by 350
Blood‐based detection of <i><scp>RAS</scp></i> mutations to guide anti‐<scp>EGFR</scp> therapy in colorectal cancer patients: concordance of results from circulating tumor <scp>DNA</scp> and tissue‐based <i><scp>RAS</scp></i> testingWolff Schmiegel, Stephen B. Fox, Rodney J. Scott et al.|Molecular Oncology|2017Cited by 161